Agilon Health Faces Growing Losses Despite Strong Revenue Growth

November 6, 2025 - 08:17

Agilon Health (AGL) continues to grapple with significant financial challenges as it reports another unprofitable quarter. Over the past five years, the company has seen its losses accelerate at an average annual rate of 7.9%, raising concerns among investors. The net profit margins remain stagnant, indicating that there is no immediate relief in sight for the company's financial woes.

Despite these struggles, Agilon Health is projected to achieve a revenue growth rate of 10.62% annually, slightly surpassing the broader US market's expected growth rate of 10.5%. This growth may attract value investors, particularly given the company's discounted share price and an exceptionally low price-to-sales ratio of 0.1x. However, the outlook remains cautious as analysts predict that Agilon will remain unprofitable for at least the next three years, which could test the resolve of bullish investors hoping for a turnaround.